RecruitingNCT07656324
Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related Fatigue
Sponsor
Fudan University
Enrollment
1,000,000 participants
Start Date
Jan 17, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Male or female, aged 18 years or older.
- Able to understand the purpose of this survey study, willing to participate, and able to sign an informed consent form.
- Malignant tumor confirmed histologically or cytologically.
Exclusion Criteria6
- Pregnant or breastfeeding women.
- Patients with acute or chronic infections, or those with other serious medical conditions that, in the investigator's judgment, make them unsuitable for this study.
- Patients with two or more concurrent malignant tumors (excluding the following: cured basal cell carcinoma of the skin, carcinoma in situ of the cervix, and papillary thyroid carcinoma).
- Patients with psychiatric illness or mental disorders, poor compliance, or who are unable to cooperate and report treatment responses.
- Patients with severe organic disease or major organ failure, such as decompensated heart, lung, liver, or kidney failure.
- Patients with other conditions that, in the investigator's opinion, make them unsuitable for participation in this study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNo Interventions
No Interventions
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07656324
Related Trials
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
NCT074543307 locations
A Natural History Study of Metabolic Sizing in Health and Disease
NCT053987831 location
Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis
NCT040851592 locations
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
NCT067566071 location
Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated With Immunotherapy and Chemotherapy in the Maintenance Phase
NCT064417733 locations